X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (16) 16
index medicus (10) 10
male (10) 10
female (8) 8
middle aged (8) 8
aged (7) 7
cardiac & cardiovascular systems (7) 7
internal medicine (7) 7
cardiovascular (6) 6
abridged index medicus (5) 5
advanced heart failure (5) 5
animals (5) 5
cardiomyopathy (5) 5
clinical competence (5) 5
dogs (5) 5
fellowship training (5) 5
heart transplantation (5) 5
mechanical circulatory support (5) 5
pulmonary hypertension (5) 5
training milestones (5) 5
transplant cardiology (5) 5
treatment outcome (5) 5
ventricular assist devices (5) 5
acc/aha/hfsa/ishlt/acp training statement (4) 4
cardiovascular disease (4) 4
guidelines (4) 4
heart (4) 4
heart failure (4) 4
mortality (4) 4
myocardial infarction (4) 4
risk (4) 4
biochemistry & molecular biology (3) 3
capillary permeability (3) 3
cardiopulmonary bypass (3) 3
cardiovascular system (3) 3
care (3) 3
chromium (3) 3
devices (3) 3
diabetes (3) 3
double-blind method (3) 3
hematology (3) 3
international society (3) 3
kaplan-meier estimate (3) 3
medicine (3) 3
medicine, general & internal (3) 3
patients (3) 3
prospective studies (3) 3
recipients (3) 3
restenosis (3) 3
stroke (3) 3
time factors (3) 3
training (3) 3
united states (3) 3
acetylcholine - pharmacology (2) 2
adult (2) 2
american heart association (2) 2
amino acids (2) 2
angioplasty (2) 2
anticoagulants (2) 2
association (2) 2
atrial fibrillation (2) 2
atrial-fibrillation (2) 2
blood proteins - metabolism (2) 2
cardiac disease (2) 2
cardiac patients (2) 2
cardiology (2) 2
cardiology and cardiovascular medicine (2) 2
cardiovascular diseases - prevention & control (2) 2
cerebral infarction (2) 2
clinical medicine (2) 2
coronary artery disease (2) 2
coronary circulation (2) 2
coronary disease - metabolism (2) 2
coronary vessels - metabolism (2) 2
diabetes mellitus (2) 2
diabetes mellitus, type 2 - complications (2) 2
diabetes mellitus, type 2 - drug therapy (2) 2
dosage and administration (2) 2
drug administration schedule (2) 2
drug therapy (2) 2
drug-eluting stent (2) 2
dysfunction (2) 2
enteral nutrition (2) 2
follow-up studies (2) 2
forestry (2) 2
health risk assessment (2) 2
heart attacks (2) 2
heart diseases (2) 2
hemodynamics (2) 2
hypoglycemic agents - administration & dosage (2) 2
in vitro techniques (2) 2
incidence (2) 2
injections, subcutaneous (2) 2
life sciences (2) 2
medical societies (2) 2
metaanalysis (2) 2
myocardial reperfusion (2) 2
oral anticoagulation (2) 2
outcome assessment (2) 2
oxidative stress (2) 2
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
by Hernandez, Adrian F and Green, Fiona and Green, Jennifer B and Janmohamed, Salim and D'Agostino, Ralph B and Granger, Christopher B and Jones, Michael and Jones, Nigel P and Leiter, Lawrence A and Rosenberg, Anne E and Rosenberg, Anne and Sigmon, Kristina and Sigmon, Kristina N and Somerville, Matthew and Somerville, Matthew C and Thorpe, Karl and Thorpe, Karl M and McMurray, John J V and McMurray, John J.V and Del Prato, Stefano and Califf, Robert M and Holman, Rury and DeMets, David and Riddle, Matthew and Goodman, Shaun and McGuire, Darren and Alexander, Karen and Devore, Adam and Melloni, Chiara and Patel, Chetan and Patel, Rajesh and Patel, Vickas and Patel, Prashant and Patel, Rajivkumar and Kong, David and Bloomfield, Gerald and Roe, Matthew and Tricoci, Pierluigi and Harrison, Rob and Harrison, Lindsay and Lopes, Renato and Mathews, Robin and Mehta, Anand and Mehta, Rajendra and Schuyler Jones, William and Vemulapalli, Sreekanth and Povsic, Thomas and Eapen, Zubin and Dombrowski, Keith and Kolls, Brad and Jordan, Dedrick and Ambrosy, Andrew and Greene, Deb and Greene, Stephen and Mandawat, Aditya and Shavadia, Jay and Cooper, John and Cooper, Lauren and Sharma, Abhinav and Sharma, Richa and Guimaraes, Patricia and Friedman, Daniel and Wilson, Matt and Wilson, Tim and Endsley, Patricia and Gentry, Tracy and Collier, Jeannie and Perez, Kathleen and James, Kourtnei and James, Rachel and Roush, Jennifer and Pope, Connie and Howell, Christina and Johnson, Megan and Johnson, David and Johnson, Andrew and Bailey, Matt and Cole, Joanna and Akers, Teresa and Vandyne, Beth and Thomas, Betsy and Rich, Jenny and Bartone, Susan and Beaulieu, Gail and Brown, Judith and Brown, Kim and Chau, Tuan and Christian, Tamra and Coker, Rebecca and Haddock, Trevorlyn and Jenkins, Wendy and Haque, Ghazala and Marquess, Marsha and Pesarchick, Jean and Rethaford, Renee and Stone, Allegra and Al Kawas, Firas and Anderson, Michelle and Enns, Robert and Sinay, Isaac and ... and Harmony Outcomes Comm Investigator and Harmony Outcomes committees and investigators
The Lancet, ISSN 0140-6736, 10/2018, Volume 392, Issue 10157, pp. 1519 - 1529
Glucagon-like peptide 1 receptor agonists differ in chemical structure, duration of action, and in their effects on clinical outcomes. The cardiovascular... 
MEDICINE, GENERAL & INTERNAL | RISK | METAANALYSIS | MELLITUS | SAFETY | RECEPTOR AGONISTS | Hypoglycemic Agents - therapeutic use | Cardiovascular Diseases - etiology | Stroke - prevention & control | Double-Blind Method | Drug Administration Schedule | Glucagon-Like Peptide 1 - administration & dosage | Glucagon-Like Peptide 1 - analogs & derivatives | Cardiovascular Diseases - prevention & control | Humans | Middle Aged | Kaplan-Meier Estimate | Male | Treatment Outcome | Stroke - etiology | Hypoglycemic Agents - administration & dosage | Injections, Subcutaneous | Adult | Female | Aged | Myocardial Infarction - prevention & control | Diabetes Mellitus, Type 2 - drug therapy | Myocardial Infarction - etiology | Diabetes Mellitus, Type 2 - complications | Glucagon-Like Peptide 1 - therapeutic use | Myocardial infarction | Diabetic retinopathy | Heart attacks | Peptides | Glucagon | Medical services | Clinical trials | Cardiovascular disease | Thyroid gland | Incidence | Thyroid carcinoma | Randomization | Motivation | Hemoglobin | Diuretics | Diabetes mellitus (non-insulin dependent) | Glucagon-like peptide 1 | Thyroid | Cerebral infarction | Stroke | Diabetes mellitus | Pancreatitis | Health risks | Risk reduction | Disease control | Patients | Organic chemistry | Interactive systems | Pancreatic cancer | Fatalities | Infarction | Diabetes | Cardiovascular diseases | Health risk assessment
Journal Article
Journal Article
Journal Article
Journal of the American College of Cardiology, ISSN 0735-1097, 06/2017, Volume 69, Issue 24, pp. 2977 - 3001
Journal Article
Catheterization and Cardiovascular Interventions, ISSN 1522-1946, 11/2015, Volume 86, Issue 6, pp. 994 - 1001
Background The TAXUS Element (ION) platinum chromium paclitaxel‐eluting stent (PtCr‐PES) incorporates a thin (81 μm) strut design with a similar polymer and... 
coronary artery disease | paclitaxel‐eluting stent | platinum chromium | randomized controlled trial | Stent (Surgery) | Chromium | Angioplasty | Stents | Clinical outcomes
Journal Article
JACC (Journal of the American College of Cardiology), ISSN 0735-1097, 2014, Volume 63, Issue 12, pp. A1901 - A1901
Journal Article
American Family Physician, ISSN 0002-838X, 2011, Volume 83, Issue 7, pp. 819 - 826
All patients with stable coronary artery disease require medical therapy to prevent disease progression and recurrent cardiovascular events. Three classes of... 
Internal Medicine | MORTALITY | MEDICINE, GENERAL & INTERNAL | HEART-DISEASE | METAANALYSIS | MYOCARDIAL-INFARCTION | RANDOMIZED-TRIALS | CARDIOVASCULAR EVENTS | HIGH-RISK | PRIMARY HEALTH CARE | BETA-BLOCKERS | BLOOD-PRESSURE | SECONDARY PREVENTION | Calcium Channel Blockers - adverse effects | Outcome Assessment (Health Care) | Humans | Clinical Protocols | Medication Therapy Management | Secondary Prevention | Coronary Artery Disease - physiopathology | Platelet Aggregation Inhibitors - administration & dosage | Angiotensin-Converting Enzyme Inhibitors - adverse effects | Arterial Pressure - drug effects | Adrenergic beta-Antagonists - adverse effects | Platelet Aggregation - drug effects | Adrenergic beta-Antagonists - administration & dosage | Platelet Aggregation Inhibitors - adverse effects | Hypolipidemic Agents - adverse effects | Risk Reduction Behavior | Coronary Artery Disease - metabolism | Treatment Outcome | Angiotensin-Converting Enzyme Inhibitors - administration & dosage | Coronary Artery Disease - therapy | Calcium Channel Blockers - administration & dosage | Hypolipidemic Agents - administration & dosage | Lipid Metabolism - drug effects | Survival Analysis | Coronary Artery Disease - psychology | Lipoproteins, LDL - blood | Practice Guidelines as Topic | Care and treatment | Dosage and administration | Safety and security measures | Coronary heart disease | Cardiovascular agents
Journal Article
JACC (Journal of the American College of Cardiology), ISSN 0735-1097, 2017, Volume 69, Issue 7, pp. 777 - 785
Abstract Background GLORIA-AF (Global Registry on Long-Term Oral Antithrombotic Treatment in Patients with Atrial Fibrillation) is a prospective, global... 
Cardiovascular | Internal Medicine | registry | oral anticoagulation | atrial fibrillation | Stroke (Disease) | Heart | Anticoagulants (Medicine) | Heart beat | Atrial fibrillation
Journal Article